INR inowanzoshandiswa kuyera mhedzisiro yemuromo anticoagulants mune thromboembolic chirwere.Yakareba INR inoonekwa mumuromo anticoagulants, DIC, vhitamini K kushomeka, hyperfibrinolysis uye zvichingodaro.Yakapfupikiswa INR inowanzoonekwa mune hypercoagulable nyika uye thrombotic kusagadzikana.INR, inozivikanwawo seInternational Normalized Ratio, ndechimwe chezve coagulation basa rekuyedza zvinhu.INR yakavakirwa pane iyo PT reagent kuenzanisa iyo International Sensitivity Index uye kuverenga mhedzisiro kuburikidza nemafomati ane hukama.Kana iyo INR yakakwirira kwazvo, kune njodzi yekubuda ropa kusingadzoreki.INR inogona kunyatso tarisa uye kushandisa mhedzisiro yeanticoagulant zvinodhaka.Kazhinji, iyo anticoagulant drug warfarin inoshandiswa, uye INR inoda kuongororwa nguva dzese.Iwe unofanirwa kuziva kuti kana warfarin ikashandiswa, INR inofanirwa kuongororwa nguva dzose.Varwere vane venous thrombosis vanofanira kutora warfarin nemuromo, uye INR inokosha inofanira kuchengetwa pa 2.0-2.5.Kune varwere vane atrial fibrillation, inr kukosha kweoral warfarin inowanzochengetwa pakati pe2.0-3.0.INR tsika dziri pamusoro pe4.0 dzinogona kukonzera kubuda ropa kusingadzoreki, nepo INR tsika pazasi 2.0 isingape inobudirira anticoagulation.
Zvaungaita: ramba uchienda kuchipatara chenguva dzose kunoongororwa, uye teerera urongwa hwechiremba ane unyanzvi.
Beijing Succeeder nyanzvi mune thrombosis uye hemostasis diagnostic zvigadzirwa zvemusika wepasi rose.
Seimwe yemhando dzinotungamira muChina Diagnostic musika weThrombosis uye Hemostasis .SUCCEEDER yakasangana nezvikwata zveR&D,Production,Marketing Sales and Service Supplying coagulation analyzers and reagents,blood rheology analyzers ESR uye HCT analyzers platelet aggregation analyzers ine CE ISO1348 uye FDA Certification. vakanyorwa.